Proactive Investors - Run By Investors For Investors

Polarean Imaging appoints former CFO of cancer therapeutics firm as new finance boss

Charles (Chuck) Osborne, Jr joins the company from oncology group Innocrin Pharmaceuticals and would start the role with immediately
Osborne will replace outgoing CFO Bill Patrick, who will take up the post of financial controller at Polarean Inc, the group’s subsidiary

Polarean Imaging Plc (LON:POLX) has appointed the former chief financial officer (CFO) of an oncology therapeutics firm as its new finance boss.

The medical imaging firm said Charles (Chuck) Osborne, Jr, who joins the company from Innocrin Pharmaceuticals Inc, would begin the role with immediate effect and will replace outgoing CFO Bill Patrick, who would take up the post of financial controller at Polarean Inc, the group’s subsidiary.

READ: Polarean Imaging signs deal with University of British Colombia

Prior to his role at Innocrin, Osborne was CFO of anti-infective therapy group Scynexis Inc (NASDAQ:SCYX).

Richard Hullihen, Polarean’s chief executive, said Osborne’s “previous capital markets experience coupled with his knowledge of financial operations within the pharmaceutical industry will ensure strong leadership of the Company's financial function”.

View full POLX profile View Profile

Polarean Imaging PLC Timeline

Related Articles

Greenhouse full  of plants
February 01 2019
The global marijuana market is projected to reach an eye-watering US$58.90 billion between 2018 and 2023
May 21 2019
Hazer Group is the first listed Australian company to produce clean hydrogen.
May 29 2019
"We aim to continue to improve the group's profitability and manage a regular and growing dividend stream for the benefit of our shareholders," said CEO Brian Raven

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use